Live feed16:15:06·13mINSIDERFilingvia QuantisnowCEO, Diagnostics Schoenherr Thomas Edward sold $873,885 worth of shares (10,281 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 76,740 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TEM· Tempus AI Inc.TechnologyOriginal source